🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join a virtual expert panel, hosted by The Hepatitis Fund & The Lancet Gastroenterology & Hepatology, to discuss opportunities to prevent liver cancer via accelerating efforts to eliminate viral hepatitis Date: Nov 13, 2024 Time: 1200-1300 GMT Register here: us06web.zoom.us/webinar/regist… #LGCW2024 #NoHep

Looking forward to this webinar on preventing liver cancer through viral hepatitis elimination, which I'll be moderating alongside Jade Chakowa of The Hepatitis Fund next Weds, Nov 13th! More info👉linkedin.com/posts/rob-brie… Register 👉 us06web.zoom.us/webinar/regist… #LiverTwitter #NoHep

The December issue of The Lancet Gastroenterology & Hepatology is out now! A summary of content 👉linkedin.com/posts/rob-brie… #GITwitter #LiverTwitter #MedTwitter

Happening NOW - find out how liver cancer can be prevented via the elimination of viral hepatitis! A webinar for @LGCW2024 in conjunction with The Hepatitis Fund Register and watch: us06web.zoom.us/webinar/regist…… #LiverTwitter #OncTwitter #NoHep

WHO's funmi lesi is the first speaker, introducing the urgent need to address viral hepatitis, the importance of the new #hepatitisB guidelines, and the four key actions that can drive global hepatitis elimination by 2030 #LiverTwitter #OncTwitter #NoHep

funmi lesi Lewis Roberts now discusses the global liver cancer situation - liver cancer is lethal, widespread, and affects those of working age disproportionately, and viral hepatitis is a critical, treatable, risk factor #LiverTwitter #OncTwitter #NoHep

funmi lesi Lewis Roberts Rachel Halford, CEO The Hepatitis C Trust, discusses the vital role of timely testing for #HCV for liver cancer prevention, told through Neil's story - watch the video here: youtube.com/watch?v=7OTRfp… #LiverTwitter #OncTwitter #NoHep #LGCW2024

funmi lesi Lewis Roberts The Hepatitis C Trust Rachel and authors from the World Hepatitis Alliance introduce the first World Hepatitis Testing Week, taking place next week Nov 18th, in this new Comment: thelancet.com/journals/langa… #LiverTwitter #OncTwitter #NoHep #LGCW2024

funmi lesi Lewis Roberts The Hepatitis C Trust World Hepatitis Alliance .@simbamabaya from Gavi, the Vaccine Alliance outlines the importance of #HBV vaccination, and particularly scaling up availability of birth dose HBV vaccines #LiverTwitter #OncTwitter #NoHep #LGCW2024

Maia Tsereteli (National Centre for Disease Control & Public Health, Georgia) & Kiyono Souichirou (MoH, Japan) share national experiences—and great successes—in tackling viral hepatitis & liver cancer #LGCW2024 #LiverTwitter #OncTwitter

Sonali Johnson (@UICC) discusses how to bring together hepatitis & oncology communities to accelerate elimination of viral hepatitis & prevention of liver cancer; we must "demand a seat at the table" in development of national cancer control policies #LGCW2024 #LiverTwitter

Union for International #CancerControl Rachel Halford (who is also president of World Hepatitis Alliance) sums up. We have the tools to tackle viral hepatitis + prevent liver cancer; "no-one should have to die from liver cancer" #LiverTwitter #OncTwitter #NoHep #LGCW2024

Attending #TLM24? Rob Brierley, Editor-in-Chief, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q01CYmHX0 #LiverTwitter

Individuals with type 2 diabetes are at higher risk for clinically relevant liver disease. Could including liver health checks in annual diabetes reviews allow early interventions to prevent end-stage liver disease? thelancet.com/journals/langa… #LiverTwitter #WorldDiabetesDay

In case you missed the webinar we hosted with The Lancet Gastroenterology & Hepatology at @LGCW2024 on how to prevent #livercancer via #hepatitis elimination, you can watch it here: youtu.be/fsNokMoNh4s?si… #LiverTwitter

The first-ever #HepTestWeek is here! Viral hepatitis is the leading cause of liver cancer. Knowing your hepatitis status is the first step to accessing life-saving treatment and care. This week, take charge of your health—get tested for hepatitis! 💪 Protect yourself, your

In the latest episode of our podcast, we talked to #PeterDeCruz about what the results of the PREDICT-UC trial mean for the management of people with steroid-refractory acute severe ulcerative colitis (ASUC) 🔊buzzsprout.com/admin/1728646/… 📃thelancet.com/journals/langa…

New research - D’Haens et al - Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial thelancet.com/journals/langa… #GITwitter #IBD

Giving Bluesky a go... bsky.app/profile/robbri… #GITwitter #LiverTwitter

It's that time of the year when journal metrics are updated... Thanks, as ever, to our authors, peer reviewers, advisory board, & colleagues, who enable us to continue publishing work that changes the lives of those living with digestive diseases. #GITwitter #LiverTwitter